Attached files
| file | filename |
|---|---|
| EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - NAVIDEA BIOPHARMACEUTICALS, INC. | navb_ex21-1.htm |
| EX-32.2 - CERTIFICATION - NAVIDEA BIOPHARMACEUTICALS, INC. | navb_ex32-2.htm |
| EX-32.1 - CERTIFICATION - NAVIDEA BIOPHARMACEUTICALS, INC. | navb_ex32-1.htm |
| EX-31.2 - CERTIFICATION - NAVIDEA BIOPHARMACEUTICALS, INC. | navb_ex31-2.htm |
| EX-31.1 - CERTIFICATION - NAVIDEA BIOPHARMACEUTICALS, INC. | navb_ex31-1.htm |
| EX-24.1 - POWER OF ATTORNEY - NAVIDEA BIOPHARMACEUTICALS, INC. | navb_ex24-1.htm |
| EX-23.2 - CONSENTS OF EXPERTS AND COUNSEL - NAVIDEA BIOPHARMACEUTICALS, INC. | navb_ex23-2.htm |
| EX-3.1 - ARTICLES OF INCORPORATION / BYLAWS - NAVIDEA BIOPHARMACEUTICALS, INC. | navb_ex3-1.htm |
| 10-K - NAVIDEA BIOPHARMACEUTICALS FORM 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | navb_10k.htm |
Exhibit
23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S
CONSENT
We
consent to the incorporation by reference in the Registration
Statement of Navidea Biopharmaceuticals, Inc. on Form S-3 (File
Nos. 333-195806, 333-193330, 333-184173, 333-173752, 333-168485,
333-76151, and 333-15989) and Form S-8 (Nos. 33-81410, 333-119219,
333-130636, 333-130640, 333-153110, 333-158323, 333-183317,
333-05143, 333-21053, 333-05143, and 333-198716) of our report
dated March 31, 2017, with respect to our audit of the consolidated
financial statements of Navidea Biopharmaceuticals, Inc. as of
December 31, 2016 and for the year then ended and our report dated
March 31, 2017 with respect to our audit of the effectiveness of
internal control over financial reporting of Navidea
Biopharmaceuticals, Inc. as of December 31, 2016, which reports are
included in this Annual Report on Form 10-K of Navidea
Biopharmaceuticals, Inc. for the year ended December 31,
2016.
Our
report on the effectiveness of internal control over financial
reporting expressed an adverse opinion because of the existence of
material weaknesses.
/s/
Marcum llp
New
Haven, Connecticut
March
31, 2017